Gilead said chronichepatitis B affects more than 400 million people worldwide.
2
Methods: One hundred forty-two unselected patients with chronichepatitis C were included.
3
Conclusions: Entecavir therapy showed excellent efficacy in nucleoside-naive chronichepatitis B patients.
4
Background and aim: Entecavir has demonstrated clinical efficacy for chronichepatitis B.
5
This review focuses on the current treatment concepts for chronichepatitis B.
1
One patient with recurrenthepatitis B developed chronic severe hepatitis B despite treatment.
2
The severity of recurrenthepatitis C virus (HCV) is likely related to several factors.
3
Methods: Twenty-nine cases of recurrenthepatitis C and 26 cases of ACR were included in this study.
4
One patient died of recurrenthepatitis C and graft failure without evidence of tuberculous infection at death.
5
Conclusions: Improving the outcome of recurrenthepatitis C may be achieved by reducing overall immunosuppression and avoiding abrupt variations in immunosuppression.
Uso de chronic liver inflammation en inglés
1
ME3738 is a new compound that attenuates liver disease in several models of acute and chronicliverinflammation.
2
Background: Hepatitis C infection induces an acute and chronicliverinflammation that may lead to cirrhosis, liver failure, or hepatocarcinoma.